chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Triangular rash at the injection site the size of her pointing finger; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Triangular rash at the injection site the size of her pointing finger) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced INJECTION SITE RASH (Triangular rash at the injection site the size of her pointing finger). At the time of the report, INJECTION SITE RASH (Triangular rash at the injection site the size of her pointing finger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Headache, Pain, Pyrexia
Clinical narrative: severe pain in every inch of my body; just my arms and legs were weak; light headedness; severe headache just in my forehead only; 101.1 F Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (severe pain in every inch of my body), ASTHENIA (just my arms and legs were weak), DIZZINESS (light headedness), HEADACHE (severe headache just in my forehead only) and PYREXIA (101.1 F Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FAMOTIDINE, MONTELUKAST, DOXEPINE, SERTRALINE, PROPRANOLOL, SUCRALFATE (CARAFATE), SIMVASTATIN, LOSARTAN, BUPROPION HYDROCHLORIDE (WELLBUTRIN), DULAGLUTIDE (TRULICITY), METFORMIN HYDROCHLORIDE (METFORMIN XR), MECLIZINE [MECLOZINE], ONDANSETRON (ZOFRAN [ONDANSETRON]) and OXYCODONE HYDROCHLORIDE;PARACETAMOL for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (severe pain in every inch of my body), ASTHENIA (just my arms and legs were weak), DIZZINESS (light headedness), HEADACHE (severe headache just in my forehead only) and PYREXIA (101.1 F Fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. On 16-Mar-2021, PAIN (severe pain in every inch of my body), ASTHENIA (just my arms and legs were weak), DIZZINESS (light headedness), HEADACHE (severe headache just in my forehead only) and PYREXIA (101.1 F Fever) had resolved.            Concomitant medication includes OTC supplements.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow-up contained no new information. On 17-Jul-2021: Follow-up contained no new information. On 26-Jul-2021: Follow-up contained no new information.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: headache; nausea; body aches; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (body aches), CHILLS (chills) and FATIGUE (fatigue). On 19-Mar-2021, the patient experienced HEADACHE (headache) and NAUSEA (nausea). At the time of the report, PAIN (body aches), CHILLS (chills), FATIGUE (fatigue), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products also include STATIN  No treatment medications were reported
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypothermia
Clinical narrative: Lower Body Temperature; Fatigue; A spontaneous report was received from a consumer concerning a 53 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events  Low body temperature/ Hypothermi and fatigue.  The patient's medical history was not provided.  concomitant product use was not provided  by the reporter.     On 17 Feb 2021 The patient received their first of two planned doses of mRNA-1273 (Batch number not provided) . On 10 Mar 2021  prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly in the Left arm for prophylaxis of COVID-19 infection.    On 10 Mar 2021, after Second  dose of vaccination, patient experienced the events Lower Body temperature and chills and the  Lower Body Temperature  is Medically significant. Treatment information was not provided.   The patient received both scheduled doses of mRNA-1273 prior to the events  therefore, action taken with the drug in response to the events  is not applicable.  The outcome of events, Lower Body temperature and fatigue were Unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site warmth
Clinical narrative: large red rash at the injection site; large red rash at the injection site; hot to touch at the injection site; very itchy at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (large red rash at the injection site), VACCINATION SITE ERYTHEMA (large red rash at the injection site), VACCINATION SITE WARMTH (hot to touch at the injection site) and VACCINATION SITE PRURITUS (very itchy at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE RASH (large red rash at the injection site), VACCINATION SITE ERYTHEMA (large red rash at the injection site), VACCINATION SITE WARMTH (hot to touch at the injection site) and VACCINATION SITE PRURITUS (very itchy at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (large red rash at the injection site), VACCINATION SITE ERYTHEMA (large red rash at the injection site), VACCINATION SITE WARMTH (hot to touch at the injection site) and VACCINATION SITE PRURITUS (very itchy at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dry mouth, Dyspnoea, Feeling abnormal, Hypogeusia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNEA (Lack of breath), INSOMNIA (lack of sleep), HYPOGEUSIA (no taste), COUGH (cough) and DRY MOUTH (dry mouth) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNEA (Lack of breath), INSOMNIA (lack of sleep), HYPOGEUSIA (no taste), COUGH (cough), DRY MOUTH (dry mouth) and FEELING ABNORMAL (felt bad). At the time of the report, DYSPNOEA (Lack of breath), INSOMNIA (lack of sleep), HYPOGEUSIA (no taste), COUGH (cough), DRY MOUTH (dry mouth) and FEELING ABNORMAL (felt bad) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-052962.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNEA (Lack of breath), INSOMNIA (lack of sleep), HYPOGEUSIA (no taste), COUGH (cough) and DRY MOUTH (dry mouth) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNEA (Lack of breath), INSOMNIA (lack of sleep), HYPOGEUSIA (no taste), COUGH (cough), DRY MOUTH (dry mouth) and FEELING ABNORMAL (felt bad). At the time of the report, DYSPNOEA (Lack of breath), INSOMNIA (lack of sleep), HYPOGEUSIA (no taste), COUGH (cough), DRY MOUTH (dry mouth) and FEELING ABNORMAL (felt bad) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-052962.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site warmth
Clinical narrative: sore arm; warm arm; red arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 004M20A) for COVID-19 vaccination.     No Medical History Information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE ERYTHEMA (red arm). 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm arm). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) outcome was unknown.            No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional document received and contains non significant information. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 23-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 004M20A) for COVID-19 vaccination.     No Medical History Information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE ERYTHEMA (red arm). 17-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm arm). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE WARMTH (warm arm) and VACCINATION SITE ERYTHEMA (red arm) outcome was unknown.            No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Additional document received and contains non significant information.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: I want to register in the pregnancy registry; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (I want to register in the pregnancy registry) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 immunisation.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The patient's last menstrual period was on 12-Oct-2020 and the estimated date of delivery was 19-Jul-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (I want to register in the pregnancy registry). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-first week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (I want to register in the pregnancy registry) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: sore arm; nausea; chills; fatigue; rapid heartbeat; lightheadedness; brain fog; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (rapid heartbeat), DIZZINESS (lightheadedness), FEELING ABNORMAL (brain fog), VACCINATION SITE PAIN (sore arm) and FATIGUE (fatigue) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tooth extraction (Wisdom tooth extraction.) and PAP smear (Abnormal Pap smear of cervix). Previously administered products included for an unreported indication: TETANUS VACCINE on 18-Sep-2019. Concurrent medical conditions included Asthma (1990), Drug allergy (ibuprofen), Allergy to arthropod bite, Seasonal allergy and Cold intolerance. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for Asthma, ALBUTEROL [SALBUTAMOL] from 10-Mar-2021 to an unknown date for Wheezing and Shortness of breath, LORATADINE (CLARITINE) and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) from 10-Mar-2021 to an unknown date for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced PALPITATIONS (rapid heartbeat), DIZZINESS (lightheadedness), FEELING ABNORMAL (brain fog) and FATIGUE (fatigue). On 07-Feb-2021, the patient experienced NAUSEA (nausea) and CHILLS (chills). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). On 05-Feb-2021, PALPITATIONS (rapid heartbeat) and DIZZINESS (lightheadedness) had resolved. On 07-Feb-2021, FEELING ABNORMAL (brain fog) and FATIGUE (fatigue) had resolved. On 09-Feb-2021, NAUSEA (nausea) and CHILLS (chills) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 122/82 mmHg (normal) Blood Pressure normal. On an unknown date, Heart rate: 55 (Low) Heart rate decreased.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medications were reported.  Patient went to EENT doctor, had some tests and all look normal.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Follow up document was attached which contains VAER having additional information for Dose 1 events ( rapid heartbeat, lightheadedness, brain fog, chills, sore arm  and fatigue) and Dose 2 events
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Nausea, Palpitations, Vaccination site pain
Clinical narrative: sore arm; nausea; chills; fatigue; rapid heartbeat; lightheadedness; brain fog; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (rapid heartbeat), DIZZINESS (lightheadedness), FEELING ABNORMAL (brain fog), VACCINATION SITE PAIN (sore arm) and FATIGUE (fatigue) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tooth extraction (Wisdom tooth extraction.) and PAP smear (Abnormal Pap smear of cervix). Previously administered products included for an unreported indication: TETANUS VACCINE on 18-Sep-2019. Concurrent medical conditions included Asthma (1990), Drug allergy (ibuprofen), Allergy to arthropod bite, Seasonal allergy and Cold intolerance. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for Asthma, ALBUTEROL [SALBUTAMOL] from 10-Mar-2021 to an unknown date for Wheezing and Shortness of breath, LORATADINE (CLARITINE) and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) from 10-Mar-2021 to an unknown date for an unknown indication.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced PALPITATIONS (rapid heartbeat), DIZZINESS (lightheadedness), FEELING ABNORMAL (brain fog) and FATIGUE (fatigue). On 07-Feb-2021, the patient experienced NAUSEA (nausea) and CHILLS (chills). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). On 05-Feb-2021, PALPITATIONS (rapid heartbeat) and DIZZINESS (lightheadedness) had resolved. On 07-Feb-2021, FEELING ABNORMAL (brain fog) and FATIGUE (fatigue) had resolved. On 09-Feb-2021, NAUSEA (nausea) and CHILLS (chills) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 122/82 mmHg (normal) Blood Pressure normal. On an unknown date, Heart rate: 55 (Low) Heart rate decreased.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment medications were reported.  Patient went to EENT doctor, had some tests and all look normal.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Follow up document was attached which contains VAER having additional information for Dose 1 events ( rapid heartbeat, lightheadedness, brain fog, chills, sore arm  and fatigue) and Dose 2 events
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Influenza like illness, Pain
Clinical narrative: feel like they "got hit by a truck"; very tired; flu-like symptoms; body aches; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feel like they "got hit by a truck"), FATIGUE (very tired), INFLUENZA LIKE ILLNESS (flu-like symptoms) and PAIN (body aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced FEELING ABNORMAL (feel like they "got hit by a truck"), FATIGUE (very tired), INFLUENZA LIKE ILLNESS (flu-like symptoms) and PAIN (body aches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (feel like they "got hit by a truck"), FATIGUE (very tired), INFLUENZA LIKE ILLNESS (flu-like symptoms) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Vaccination site erythema
Clinical narrative: Sore arm; nausea; Fatigue; chills; Headache; injection site red; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE PAIN (injection site tender), FATIGUE (Fatigue) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site red) and VACCINATION SITE PAIN (injection site tender). On 20-Mar-2021, the patient experienced NAUSEA (nausea), FATIGUE (Fatigue), CHILLS (chills) and HEADACHE (Headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). On 13-Mar-2021, VACCINATION SITE ERYTHEMA (injection site red) was resolving, VACCINATION SITE PAIN (injection site tender) had resolved. At the time of the report, NAUSEA (nausea), FATIGUE (Fatigue), CHILLS (chills) and HEADACHE (Headache) was resolving and PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Aspirin. Concomitant medications included blood pressure medicine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm; nausea; Fatigue; chills; Headache; injection site red; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VACCINATION SITE ERYTHEMA (injection site red), VACCINATION SITE PAIN (injection site tender), FATIGUE (Fatigue) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site red) and VACCINATION SITE PAIN (injection site tender). On 20-Mar-2021, the patient experienced NAUSEA (nausea), FATIGUE (Fatigue), CHILLS (chills) and HEADACHE (Headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). On 13-Mar-2021, VACCINATION SITE ERYTHEMA (injection site red) was resolving, VACCINATION SITE PAIN (injection site tender) had resolved. At the time of the report, NAUSEA (nausea), FATIGUE (Fatigue), CHILLS (chills) and HEADACHE (Headache) was resolving and PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Aspirin. Concomitant medications included blood pressure medicine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature decreased, Chills, Dizziness, Headache
Clinical narrative: a fever of 101 degrees Farenheight; upset stomach; headache; mild body aches; Chills; shaking; severe dizziness; felt cold; could not get warm; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (mild body aches), CHILLS (Chills), PYREXIA (a fever of 101 degrees Farenheight) and TREMOR (shaking) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 18-Mar-2021, the patient experienced HEADACHE (headache), MYALGIA (mild body aches), CHILLS (Chills), TREMOR (shaking), DIZZINESS (severe dizziness), NASOPHARYNGITIS (felt cold), BODY TEMPERATURE DECREASED (could not get warm) and PYREXIA (slight fever). On an unknown date, the patient experienced PYREXIA (a fever of 101 degrees Farenheight) and ABDOMINAL DISCOMFORT (upset stomach). At the time of the report, HEADACHE (headache), MYALGIA (mild body aches), CHILLS (Chills), PYREXIA (a fever of 101 degrees Farenheight), TREMOR (shaking), DIZZINESS (severe dizziness), NASOPHARYNGITIS (felt cold), BODY TEMPERATURE DECREASED (could not get warm), PYREXIA (slight fever) and ABDOMINAL DISCOMFORT (upset stomach) outcome was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasopharyngitis, Pyrexia, Tremor
Clinical narrative: a fever of 101 degrees Farenheight; upset stomach; headache; mild body aches; Chills; shaking; severe dizziness; felt cold; could not get warm; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), MYALGIA (mild body aches), CHILLS (Chills), PYREXIA (a fever of 101 degrees Farenheight) and TREMOR (shaking) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 18-Mar-2021, the patient experienced HEADACHE (headache), MYALGIA (mild body aches), CHILLS (Chills), TREMOR (shaking), DIZZINESS (severe dizziness), NASOPHARYNGITIS (felt cold), BODY TEMPERATURE DECREASED (could not get warm) and PYREXIA (slight fever). On an unknown date, the patient experienced PYREXIA (a fever of 101 degrees Farenheight) and ABDOMINAL DISCOMFORT (upset stomach). At the time of the report, HEADACHE (headache), MYALGIA (mild body aches), CHILLS (Chills), PYREXIA (a fever of 101 degrees Farenheight), TREMOR (shaking), DIZZINESS (severe dizziness), NASOPHARYNGITIS (felt cold), BODY TEMPERATURE DECREASED (could not get warm), PYREXIA (slight fever) and ABDOMINAL DISCOMFORT (upset stomach) outcome was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Gastrooesophageal reflux disease, Nausea
Clinical narrative: bad acid reflux; raised blood sugar; nausea; This spontaneous case was reported by a consumer and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (bad acid reflux), BLOOD GLUCOSE INCREASED (raised blood sugar) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (bad acid reflux), BLOOD GLUCOSE INCREASED (raised blood sugar) and NAUSEA (nausea). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (bad acid reflux), BLOOD GLUCOSE INCREASED (raised blood sugar) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient Wondering if she could take Zofran for side effects such as nausea
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm is swollen, hot, red, sore; Arm is swollen, hot, red, sore; Headache; Arm is swollen, hot, red, sore; Arm is swollen, hot, red, sore; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE SWELLING, VACCINATION SITE ERYTHEMA, HEADACHE, VACCINATION SITE WARMTH, and PAIN IN EXTREMITY in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE SWELLING, VACCINATION SITE ERYTHEMA, HEADACHE, VACCINATION SITE WARMTH, and PAIN IN EXTREMITY. At the time of the report, VACCINATION SITE SWELLING , VACCINATION SITE ERYTHEMA, HEADACHE, VACCINATION SITE WARMTH, and PAIN IN EXTREMITY outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: red patches on stomach that are extremely itchy; itching area in arm; skin rash; Swollen hot; hot to the touch in area of arm; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch in area of arm), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (red patches on stomach that are extremely itchy), VACCINATION SITE PRURITUS (itching area in arm) and VACCINATION SITE RASH (skin rash) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044821A and 037132AA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Eczema and Back distress. Concomitant products included TRIAMCINOLONE and MELOXICAM for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 21-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch in area of arm), VACCINATION SITE PRURITUS (itching area in arm), VACCINATION SITE RASH (skin rash) and VACCINATION SITE SWELLING (Swollen hot). On 09-Apr-2021, the patient experienced ERYTHEMA (red patches on stomach that are extremely itchy). At the time of the report, VACCINATION SITE WARMTH (hot to the touch in area of arm), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (red patches on stomach that are extremely itchy), VACCINATION SITE PRURITUS (itching area in arm), VACCINATION SITE RASH (skin rash) and VACCINATION SITE SWELLING (Swollen hot) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was given.   This case was linked to MOD21-074447, US-MODERNATX, INC.-MOD-2021-075201 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow up  information on 13-APR-2021 include patient's Date of Birth, medical history(Eczema, back problems). Administration of Moderna vaccine second dose was added. Concomitant product information (triamcinolone cream, meloxicam) were added. Events erythema,Skin rash,  vaccination site swelling were  added. Event sore arm was upgraded to pain in arm . Date of reaction start were added.; Sender's Comments:  MOD21-074447:1st dose US-MODERNATX, INC.-MOD-2021-075201:1st dose
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: red patches on stomach that are extremely itchy; itching area in arm; skin rash; Swollen hot; hot to the touch in area of arm; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch in area of arm), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (red patches on stomach that are extremely itchy), VACCINATION SITE PRURITUS (itching area in arm) and VACCINATION SITE RASH (skin rash) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044821A and 037132AA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Eczema and Back distress. Concomitant products included TRIAMCINOLONE and MELOXICAM for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 21-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch in area of arm), VACCINATION SITE PRURITUS (itching area in arm), VACCINATION SITE RASH (skin rash) and VACCINATION SITE SWELLING (Swollen hot). On 09-Apr-2021, the patient experienced ERYTHEMA (red patches on stomach that are extremely itchy). At the time of the report, VACCINATION SITE WARMTH (hot to the touch in area of arm), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (red patches on stomach that are extremely itchy), VACCINATION SITE PRURITUS (itching area in arm), VACCINATION SITE RASH (skin rash) and VACCINATION SITE SWELLING (Swollen hot) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was given.   This case was linked to MOD21-074447, US-MODERNATX, INC.-MOD-2021-075201 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow up  information on 13-APR-2021 include patient's Date of Birth, medical history(Eczema, back problems). Administration of Moderna vaccine second dose was added. Concomitant product information (triamcinolone cream, meloxicam) were added. Events erythema,Skin rash,  vaccination site swelling were  added. Event sore arm was upgraded to pain in arm . Date of reaction start were added.; Sender's Comments:  MOD21-074447:1st dose US-MODERNATX, INC.-MOD-2021-075201:1st dose
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: soreness of injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (soreness of injection site) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20a and 006m20a) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE PAIN (soreness of injection site). On 24-Jan-2021, INJECTION SITE PAIN (soreness of injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment IV fluids
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Hyperglycaemia, Vertigo
Clinical narrative: Experiencing vertigo; morning sugar is up to 135-140 without eating any sugar; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (morning sugar is up to 135-140 without eating any sugar) and VERTIGO (Experiencing vertigo) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HYPERGLYCAEMIA (morning sugar is up to 135-140 without eating any sugar). In June 2021, the patient experienced VERTIGO (Experiencing vertigo). At the time of the report, HYPERGLYCAEMIA (morning sugar is up to 135-140 without eating any sugar) and VERTIGO (Experiencing vertigo) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Blood glucose increased: 135-140 (High) Morning sugar is up to 135-140 without eating any sugar.         Concomitant product use was not provided by the reporter.  No treatment information was provided.  Patient stated that he did not think that vertigo was related to vaccine but he was not sure.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow-up received contains newevent.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Insomnia
Clinical narrative: Anxiety; Not able to sleep well; A spontaneous report was received from a consumer concerning a 69-year- old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced anxiety and was not able to sleep.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.     The patient received their first of two planned doses of mRNA-1273 (Batch number: 026L20A) on 27 Jan 2021.  On 24 Feb 2021, prior to the onset of the symptoms, the patient received their second of two planned doses of mRNA-1273 (Batch number: 002A21A) through unknown route in the left arm for prophylaxis of COVID-19 infection.  On 11 Mar 2021, Patient reported that she was anxious and not able to sleep well. She had taken Xanax and has been having chamomile tea.   Treatment for the event included Xanax.    The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.  The outcome of the events was not reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Illness, Peripheral swelling, Skin discolouration
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very sick), PERIPHERAL SWELLING (Arm is very swollen, black and blue), SKIN DISCOLOURATION (Arm is very swollen, black and blue) and DYSPHONIA (Voice is shaking) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006BZ1A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (And was worse) in December 2020. On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced ILLNESS (Very sick), PERIPHERAL SWELLING (Arm is very swollen, black and blue), SKIN DISCOLOURATION (Arm is very swollen, black and blue) and DYSPHONIA (Voice is shaking). The patient was treated with PARACETAMOL (TYLENOL) for Sickness, at an unspecified dose and frequency. At the time of the report, ILLNESS (Very sick), PERIPHERAL SWELLING (Arm is very swollen, black and blue), SKIN DISCOLOURATION (Arm is very swollen, black and blue) and DYSPHONIA (Voice is shaking) had not resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product were not provided by the reporter. After second dose patient experienced headache. This case was linked to MOD-2021-269008. Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Patient medical history includes COVID was added.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Myalgia, Nasal congestion
Clinical narrative: lost his sense of smell; lost his sense of taste; body aches; slight fever; chills; nose was congested; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nose was congested), ANOSMIA (lost his sense of smell), AGEUSIA (lost his sense of taste), MYALGIA (body aches) and PYREXIA (slight fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced NASAL CONGESTION (nose was congested), MYALGIA (body aches), PYREXIA (slight fever) and CHILLS (chills). On 20-Mar-2021, the patient experienced ANOSMIA (lost his sense of smell) and AGEUSIA (lost his sense of taste). At the time of the report, NASAL CONGESTION (nose was congested), ANOSMIA (lost his sense of smell), AGEUSIA (lost his sense of taste), MYALGIA (body aches), PYREXIA (slight fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.  No relevant concomitant medications were reported.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: lost his sense of smell; lost his sense of taste; body aches; slight fever; chills; nose was congested; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nose was congested), ANOSMIA (lost his sense of smell), AGEUSIA (lost his sense of taste), MYALGIA (body aches) and PYREXIA (slight fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced NASAL CONGESTION (nose was congested), MYALGIA (body aches), PYREXIA (slight fever) and CHILLS (chills). On 20-Mar-2021, the patient experienced ANOSMIA (lost his sense of smell) and AGEUSIA (lost his sense of taste). At the time of the report, NASAL CONGESTION (nose was congested), ANOSMIA (lost his sense of smell), AGEUSIA (lost his sense of taste), MYALGIA (body aches), PYREXIA (slight fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.  No relevant concomitant medications were reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Exposure during pregnancy) in a 35-year-old female patient (gravida 4) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included Complication of pregnancy since an unknown date and Pregnancy (She has 3 previous pregnancies and its outcome was spontaneous abortion). Concurrent medical conditions included Drug allergy (Clindamycin). Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 27-Jul-2020 and the estimated date of delivery was 03-Apr-2021. On 17-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-third week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Exposure during pregnancy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment drugs are not provided by reporter. Patient had three previous pregnancies which were miscarriages spontaneous abortion in Jul 2018, Feb2019 and Nov 2019. Had unremarkable course of current pregnancy to date except for a short cervix.